Table 3.
Primary and secondary outcomes in patients in the end of study.
| Variables | Methylprednisolone N = 30 | Standard care N = 30 | p Value | |
|---|---|---|---|---|
| Primery Outcome | Discharge, N (%) | 23 (76.7) | 15 (50) | 0.032 |
| Death, N (%) | 7 (23.3) | 15 (50) | ||
| SPO2, Mean (SD) | 88.77 (5.21) | 81.19 (7.49) | 0.001 | |
| Hospitalization length, Mean (SD) | 17.60 (8.09) | 22.97(10.62) | 0.032 | |
| Clinical finding, N (%) | GI Symptoms | 2 (6.7) | 4 (13.3) | 0.995 |
| Myalgia | 2 (6.7) | 3 (10) | ||
| Dyspnea | 5 (16.7) | 9 (30) | ||
| Cough | 5 (16.7) | 7 (23.3) | ||
| Fever | 0 | 0 | ||
| Chest pain | 1 (3.3) | 2 (6.7) | ||